HIGHLIGHTS
- who: Yurou Ji and collaborators from the Clinical School of Obstetrics and Gynecology Center, Tianjin Medical University, Tianjin, China have published the article: Anlotinib Exerts Inhibitory Effects against Cisplatin-Resistant Ovarian Cancer In Vitro and In Vivo, in the Journal: Molecules 2022, 27, x FOR PEER REVIEW of /2022/
- what: The aim of this study was to investigate the inhibitory effect of on the pathogenesis of OC. In this study showed excellent inhibitory effects against OC both in vitro and in vivo. The authors aimed to evaluate whether anlotinib exerts any effect against resistant OC . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.